{"id":55518,"date":"2025-09-29T20:43:42","date_gmt":"2025-09-29T15:13:42","guid":{"rendered":"https:\/\/www.nextias.com\/ca\/?p=55518"},"modified":"2025-09-30T14:27:38","modified_gmt":"2025-09-30T08:57:38","slug":"us-100-percent-tariff-pharma-import","status":"publish","type":"post","link":"https:\/\/www.nextias.com\/ca\/current-affairs\/29-09-2025\/us-100-percent-tariff-pharma-import","title":{"rendered":"U.S. Imposes 100% Tariff on Pharmaceuticals Import"},"content":{"rendered":"\n<p><strong>Syllabus: GS3\/ Economy<\/strong><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Context<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>The U.S. President Donald Trump announced a <strong>100% import tariff<\/strong> on branded and patented pharmaceutical products, including a <strong>25% tariff <\/strong>on imports of all heavy-duty trucks and <strong>50% tariff <\/strong>on kitchen cabinets.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>About<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Exemptions: <\/strong>The<strong> EU and Japan<\/strong> benefit from a <strong>15% tariff ceiling,<\/strong> under special trade agreements that cap duties on most goods, including pharmaceuticals.\n<ul class=\"wp-block-list\">\n<li>Companies establishing pharmaceutical plants in the U.S. are exempt, provided <strong>construction has begun or is under way.<\/strong><\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><strong>High Exposure: <\/strong>The <strong>U.K., Switzerland, and Singapore<\/strong>, being key hubs for branded drug manufacturing, face the <strong>prospect of a 100% tariff,<\/strong> which could severely increase the cost of their products in the U.S. market.<\/li>\n<\/ul>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full\"><img data-dominant-color=\"15212c\" data-has-transparency=\"false\" style=\"--dominant-color: #15212c;\" loading=\"lazy\" decoding=\"async\" width=\"489\" height=\"374\" src=\"https:\/\/wp-images.nextias.com\/cdn-cgi\/image\/format=auto\/ca\/uploads\/2025\/09\/U.S.-Imposes-100-Tariff-on-Pharmaceuticals-Import.webp\" alt=\"U.S. Imposes 100% Tariff on Pharmaceuticals Import\" class=\"not-transparent wp-image-55521\" srcset=\"https:\/\/wp-images.nextias.com\/cdn-cgi\/image\/format=auto\/ca\/uploads\/2025\/09\/U.S.-Imposes-100-Tariff-on-Pharmaceuticals-Import.webp 489w, https:\/\/wp-images.nextias.com\/cdn-cgi\/image\/format=auto\/ca\/uploads\/2025\/09\/U.S.-Imposes-100-Tariff-on-Pharmaceuticals-Import-300x229.webp 300w\" sizes=\"auto, (max-width: 489px) 100vw, 489px\" \/><\/figure>\n<\/div>\n\n\n<figure class=\"wp-block-table\"><table class=\"has-background\" style=\"background-color:#fff2cc\"><tbody><tr><td><strong>Countries Protected by Trade Deals<\/strong><br>&#8211; <strong>EU Agreement:<\/strong> A framework deal finalized in July 2025 and reiterated in late September, sets a baseline <strong>15% tariff <\/strong>on most EU goods, including pharmaceuticals.&nbsp;<br>1. The EU also committed to purchasing <strong>$750 billion in <\/strong>U.S. energy and making<strong> $600 billion<\/strong> in U.S. investments.<br>&#8211; <strong>Japan Agreement: <\/strong>A similar agreement also capped tariffs at <strong>15%<\/strong> on most goods.&nbsp;<br>1. Japan has committed to investing <strong>$550 billion<\/strong> in strategic U.S. sectors like energy, semiconductors, critical minerals, and pharmaceuticals.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Implications for the U.S. Pharma Industry<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Domestic Manufacturing Incentives:<\/strong> The tariff may encourage U.S.-based production of branded drugs, potentially strengthening domestic supply chains.<\/li>\n\n\n\n<li><strong>The industry could face higher costs <\/strong>for imported inputs, possible <strong>shortages of certain drugs<\/strong>, and a slowdown in innovation if <strong>resources are redirected<\/strong> from research to compliance and production adjustments.<\/li>\n\n\n\n<li>The <strong>Pharmaceutical Research and Manufacturers of America (PhRMA)<\/strong> warned that tariffs could <strong>increase patient costs<\/strong> without resolving underlying supply chain issues.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Implications for India\u2019s Pharma Sector<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Benefits:<\/strong> India exports over <strong>$10.5 billion<\/strong> worth of formulations annually to the U.S., mainly generic drugs, which make up <strong>90%<\/strong> of U.S. prescriptions but just <strong>13%<\/strong> of spending.\n<ul class=\"wp-block-list\">\n<li>Since the tariffs currently apply only to branded and patented drugs, India\u2019s generics are not directly targeted.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><strong>Risks Ahead:<\/strong> If tariffs expand to include<strong> generics, biosimilars, or Active Pharmaceutical Ingredients (APIs)<\/strong>, India would face a major setback.<\/li>\n<\/ul>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full\"><img data-dominant-color=\"c0c6d0\" data-has-transparency=\"false\" style=\"--dominant-color: #c0c6d0;\" loading=\"lazy\" decoding=\"async\" width=\"415\" height=\"372\" src=\"https:\/\/wp-images.nextias.com\/cdn-cgi\/image\/format=auto\/ca\/uploads\/2025\/09\/Implications-for-Indias-Pharma-Sector.webp\" alt=\"Implications for India\u2019s Pharma Sector\" class=\"not-transparent wp-image-55526\" srcset=\"https:\/\/wp-images.nextias.com\/cdn-cgi\/image\/format=auto\/ca\/uploads\/2025\/09\/Implications-for-Indias-Pharma-Sector.webp 415w, https:\/\/wp-images.nextias.com\/cdn-cgi\/image\/format=auto\/ca\/uploads\/2025\/09\/Implications-for-Indias-Pharma-Sector-300x269.webp 300w\" sizes=\"auto, (max-width: 415px) 100vw, 415px\" \/><\/figure>\n<\/div>\n\n\n<h2 class=\"wp-block-heading\"><strong>Way Ahead<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>For the world, the move is a reminder that global supply chains forged in the post <strong>World War II<\/strong> order are being reshaped by new political realities.&nbsp;<\/li>\n\n\n\n<li>Countries heavily dependent on U.S. demand are now<strong> compelled to diversify export markets<\/strong> and strengthen alternative trade alliances.<\/li>\n<\/ul>\n\n\n\n<p><strong>Source: <\/strong><a href=\"https:\/\/www.thehindu.com\/opinion\/editorial\/weaponising-health-care-on-the-trump-tariffs-on-imported-medicines\/article70105428.ece\" target=\"_blank\" rel=\"noopener\"><strong>TH<\/strong><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p><strong>Context<\/strong><\/p>\n<li class=\"ms-5\">The U.S. President Donald Trump announced a 100% import tariff on branded and patented pharmaceutical products, including a 25% tariff on imports of all heavy-duty trucks and 50% tariff on kitchen cabinets.<\/li>\n<p><\/p>\n<p><strong>About<\/strong><\/p>\n<li class=\"ms-5\">Exemptions: The EU and Japan benefit from a 15% tariff ceiling, under special trade agreements that cap duties on most goods, including pharmaceuticals.<\/li>\n<li class=\"ms-5\">Companies establishing pharmaceutical plants in the U.S. are exempt, provided construction has begun or is under way.<\/li>\n<p><a href=\"https:\/\/www.nextias.com\/ca\/current-affairs\/29-09-2025\/us-100-percent-tariff-pharma-import\" class=\"btn btn-primary btn-sm float-end\">Read\u00a0More<\/a><\/p>\n","protected":false},"author":15,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[21],"tags":[],"class_list":["post-55518","post","type-post","status-publish","format-standard","hentry","category-current-affairs"],"acf":[],"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/www.nextias.com\/ca\/wp-json\/wp\/v2\/posts\/55518","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.nextias.com\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nextias.com\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nextias.com\/ca\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nextias.com\/ca\/wp-json\/wp\/v2\/comments?post=55518"}],"version-history":[{"count":5,"href":"https:\/\/www.nextias.com\/ca\/wp-json\/wp\/v2\/posts\/55518\/revisions"}],"predecessor-version":[{"id":55555,"href":"https:\/\/www.nextias.com\/ca\/wp-json\/wp\/v2\/posts\/55518\/revisions\/55555"}],"wp:attachment":[{"href":"https:\/\/www.nextias.com\/ca\/wp-json\/wp\/v2\/media?parent=55518"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nextias.com\/ca\/wp-json\/wp\/v2\/categories?post=55518"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nextias.com\/ca\/wp-json\/wp\/v2\/tags?post=55518"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}